drugset / Trial / NCT01327235
Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites
RandomizedParallel-groupOpen-labelTreatment
Summary
The objective of this study is to compare the efficacy of Endostar/cisplatin with cisplatin alone or Endostar alone in patients with malignant pleural effusion or ascites.
Timeline
- Start
- 2011-03
- Primary completion
- 2014-04
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 40 mg | — |
| Subject | Endostar | Protein / enzyme biologic | 45 mg | Other |
| Subject | Endostar | Protein / enzyme biologic | 60 mg | Other |